Skip to main content

Table 1 Inclusion and exclusion criteria

From: The effects of polyunsaturated fatty acid (PUFA) administration on the microbiome-gut-brain axis in adolescents with anorexia nervosa (the MiGBAN study): study protocol for a longitudinal, double-blind, randomized, placebo-controlled trial

Inclusion criteria

Exclusion criteria (patient and HC group)

- Patient group: female and male patients with a diagnosis of typical or atypical AN (according to DSM-5) aged 12 to 19 years

- HC group: adolescents aged 12 to 19 years with no current psychiatric disorder and no history of eating disorder

- Antibiotic use 6 weeks before inclusion

- Diseases with an impact on the gastrointestinal tract (e.g. diabetes or inflammatory bowel disease)

- Psychotic or bipolar disorder

- Substance use disorder

- Organic brain disease

- IQ < 80

- Insufficient knowledge of German language

- Pregnancy

- For the MRI measurements: none of the standard MRI contraindications met (e.g. metal or electric implants in the body, claustrophobia)